Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones
- PMID: 36089853
- PMCID: PMC10177687
- DOI: 10.1080/20477724.2022.2121362
Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones
Abstract
For people living in developed countries life span is growing at a faster pace than ever. One of the main reasons for such success is attributable to the introduction and extensive use in the clinical practice of antibiotics over the course of the last seven decades. In hospital settings, Klebsiella pneumoniae represents a well-known and commonly described opportunistic pathogen, typically characterized by resistance to several antibiotic classes. On the other hand, the broad wedge of population living in Low and/or Middle Income Countries is increasing rapidly, allowing the spread of several commensal bacteria which are transmitted via human contact. Community transmission has been the original milieu of K. pneumoniae isolates characterized by an outstanding virulence (hypervirulent). These two characteristics, also defined as "pathotypes", originally emerged as different pathways in the evolutionary history of K. pneumoniae. For a long time, the Sequence Type (ST), which is defined by the combination of alleles of the 7 housekeeping genes of the Multi-Locus Sequence Typing, has been a reliable marker of the pathotype: multidrug-resistant clones (e.g. ST258, ST147, ST101) in the Western world and hypervirulent clones (e.g. ST23, ST65, ST86) in the Eastern. Currently, the boundaries separating the two pathotypes are fading away due to several factors, and we are witnessing a worrisome convergence in certain high-risk clones. Here we review the evidence available on confluence of multidrug-resistance and hypervirulence in specific K. pneumoniae clones.
Keywords: Klebsiella pneumoniae; carbapenem; convergence; global pathogen; hypervirulence; multidrug-resistance.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures


Similar articles
-
Multiplex PCR Analysis for Rapid Detection of Klebsiella pneumoniae Carbapenem-Resistant (Sequence Type 258 [ST258] and ST11) and Hypervirulent (ST23, ST65, ST86, and ST375) Strains.J Clin Microbiol. 2018 Aug 27;56(9):e00731-18. doi: 10.1128/JCM.00731-18. Print 2018 Sep. J Clin Microbiol. 2018. PMID: 29925644 Free PMC article.
-
Molecular and Epidemiological Characteristics of Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates in Japan.mSphere. 2020 Oct 21;5(5):e00490-20. doi: 10.1128/mSphere.00490-20. mSphere. 2020. PMID: 33087515 Free PMC article.
-
Hypervirulent Klebsiella pneumoniae: An update on epidemiology, detection and antibiotic resistance.Acta Microbiol Immunol Hung. 2023 Dec 4;70(4):278-287. doi: 10.1556/030.2023.02186. Print 2023 Dec 7. Acta Microbiol Immunol Hung. 2023. PMID: 38047929 Review.
-
Evolutionary transition of hypervirulent Klebsiella pneumoniae to multidrug-resistant hypervirulent Klebsiella pneumoniae: Indian experience.Indian J Med Microbiol. 2024 Jul-Aug;50:100619. doi: 10.1016/j.ijmmb.2024.100619. Epub 2024 Jun 12. Indian J Med Microbiol. 2024. PMID: 38848891
-
Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms.Front Cell Infect Microbiol. 2017 Nov 21;7:483. doi: 10.3389/fcimb.2017.00483. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 29209595 Free PMC article. Review.
Cited by
-
Klebsiella pneumoniae sequence type 147: a high-risk clone increasingly associated with plasmids carrying both resistance and virulence elements.J Med Microbiol. 2024 Apr;73(4):001823. doi: 10.1099/jmm.0.001823. J Med Microbiol. 2024. PMID: 38629482 Free PMC article.
-
Prevalence of carbapenem-resistant Enterobacterales with bla IMP-6 predominance in hospitals from 2018 to 2021 in Nara, Japan.JAC Antimicrob Resist. 2024 Aug 20;6(4):dlae135. doi: 10.1093/jacamr/dlae135. eCollection 2024 Aug. JAC Antimicrob Resist. 2024. PMID: 39165366 Free PMC article.
-
Highlighting the Potential of LyeTx I, a Peptide Derived from the Venom of the Spider Lycosa erythrognatha, as a Potential Prototype for the Development of a New Antimicrobial Against Carbapenem-Resistant Klebsiella pneumoniae.Pharmaceuticals (Basel). 2025 May 2;18(5):679. doi: 10.3390/ph18050679. Pharmaceuticals (Basel). 2025. PMID: 40430498 Free PMC article.
-
Genome Analysis of Klebsiella pneumoniae Reveals International High-Risk Pandemic MDR Clones Emerging in Tertiary Healthcare Settings in Uganda.Pathogens. 2023 Nov 9;12(11):1334. doi: 10.3390/pathogens12111334. Pathogens. 2023. PMID: 38003798 Free PMC article.
-
Investigation of in vitro susceptibility and resistance mechanisms to amikacin among diverse carbapenemase-producing Enterobacteriaceae.BMC Med Genomics. 2024 Oct 1;17(1):240. doi: 10.1186/s12920-024-02016-0. BMC Med Genomics. 2024. PMID: 39354545 Free PMC article.
References
-
- Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344–359. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources